ZIM LABORATORIES share price has zoomed 8% and is presently trading at Rs 113.4.
Meanwhile, the BSE HEALTHCARE index is at 36,826.7 (up 0.4%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 5.2%) and MAX HEALTHCARE INSTITUTE (up 5.1%).
KIMS (down 1.9%) and POLY MEDICURE (down 1.7%) are among the top losers today.
Over the last one year, ZIM LABORATORIES has moved up from Rs 112.1 to Rs 113.4, registering a gain of Rs 1.3 (up 1.2%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,826.7, registering a gain of 45.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 90.1%), Glenmark Pharma (up 90.0%) and GSK Pharma (up 83.8%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 78,739.7 (up 0.1%).
The top gainers among the BSE Sensex today are Ultratech Cement (up 3.2%) and JSW Steel (up 1.6%). The most traded stocks in the BSE Sensex are Tata Steel and M&M.
In the meantime, NSE Nifty is at 23,889.3 (up 0.1%). Ultratech Cement and Grasim Industries are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 78,739.7, registering a gain of 15,769.7 points (up 25.0%).
ZIM LABORATORIES net profit grew 11.7% YoY to Rs 81 million for the quarter ended March 2024, compared to a profit of Rs 72 million a year ago. Net sales rose 11.8% to Rs 1,179 million during the period as against Rs 1,054 million in January-March 2023.
For the year ended March 2024, ZIM LABORATORIES reported 29.4% decrease in net profit to Rs 172 million compared to net profit of Rs 244 million during FY23. Revenue of the company fell 7.8% to Rs 3,674 million during FY24.
The current Price to earnings ratio of ZIM LABORATORIES, based on rolling 12 month earnings, stands at 32.0.
Equitymaster requests your view! Post a comment on "ZIM LABORATORIES Gains 8%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!